Intrinsic Value of S&P & Nasdaq Contact Us

Celanese Corporation CE NYSE

NYSE • Basic Materials • Chemicals • US • USD

SharesGrow Score
31/100
0/7 Pass
SharesGrow Intrinsic Value
$1,513.21
+2224.4%
Analyst Price Target
$62.22
-4.4%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Celanese Corporation (CE) has a negative trailing P/E of -6.0, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 12.9 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -16.58%, forward earnings yield 7.75%. PEG 0.39 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (35/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -6.0); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -16.58%).
  • Forward P/E 12.9 — analysts expect a return to profitability with estimated EPS of $5.04 for FY2026.
  • PEG Ratio 0.39 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -16.58% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 7.75% as earnings recover.
  • Analyst consensus target $62.22 (-4.4% downside) — slight downside risk — the market may be ahead of analyst expectations.

Overall SharesGrow Score: 31/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
31/100
SG Score
View full scorecard →
VALUE
35/100
Price-to-Earnings & upside
Proven by this page
FUTURE
26/100
Analyst consensus
→ Forecast
~
PAST
50/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
MOAT
31/100
→ Income
GROWTH
30/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — CE

Valuation Multiples
P/E (TTM)-6.0
Forward P/E12.9
PEG Ratio0.39
Forward PEG0.39
P/B Ratio1.73
P/S Ratio0.73
EV/EBITDA63.9
Per Share Data
EPS (TTM)$-10.58
Forward EPS (Est.)$5.04
Book Value / Share$40.80
Revenue / Share$87.08
FCF / Share$7.33
Yields & Fair Value
Earnings Yield-16.58%
Forward Earnings Yield7.75%
Dividend Yield0.19%
SharesGrow IV$1,513.21 (+2224.4%)
Analyst Target$62.22 (-4.4%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 12.7 0.06 4.41 2.12 1.76%
2017 17.5 -10.88 5.11 2.40 1.63%
2018 10.0 0.21 4.05 1.69 2.32%
2019 17.9 -0.76 6.09 2.42 1.97%
2020 7.7 0.05 4.34 2.71 1.91%
2021 9.9 11.90 4.46 2.19 1.63%
2022 5.9 2.03 1.97 1.15 2.68%
2023 8.6 2.85 2.38 1.55 1.80%
2024 -5.0 0.03 1.46 0.74 4.06%
2025 -4.0 0.17 1.14 0.49 0.28%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $6.18 $5.39B $900M 16.7%
2017 $6.09 $6.14B $843M 13.7%
2018 $8.91 $7.16B $1.21B 16.9%
2019 $6.84 $6.3B $852M 13.5%
2020 $16.75 $5.66B $1.99B 35.1%
2021 $16.86 $8.54B $1.89B 22.1%
2022 $17.34 $9.67B $1.89B 19.6%
2023 $17.92 $10.94B $1.96B 17.9%
2024 $-13.93 $10.28B $-1.52B -14.8%
2025 $-10.64 $9.54B $-1.17B -12.2%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $4.97 $4.20 – $6.86 $9.48B $9.35B – $9.69B 9
2027 $6.32 $5.37 – $7.49 $9.79B $9.65B – $10.18B 9
2028 $7.68 $7.21 – $8.04 $10.16B $10.15B – $10.17B 3
2029 $11.95 $11.59 – $12.52 $8.83B $8.63B – $9.16B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message